Intellectual Property UK

  • March 28, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen sparkling winemaker Nyetimber hit a rival distillery with an intellectual property claim, Newcastle United's former owner Mike Ashley target the club's ex-vice president for damages tied to a fraudulent investment, and a real estate agency file a legal claim against law firm Winston & Strawn LLP. Here, Law360 looks at these and other new claims in the U.K.

  • March 28, 2025

    CureVac RNA Vax Patent Survives BioNTech's EU Challenge

    CureVac SE has fended off a challenge from BioNTech SE of its mRNA therapy patent at a European patent authority, paving the way for CureVac to forge ahead with litigation in the companies' home country of Germany accusing BioNTech of infringing its invention.

  • March 28, 2025

    Pharma Co. Sues Ex-VP For Trade Theft To Benefit Rival

    A pharma company has sued its former senior vice president, accusing him of secretly downloading confidential information in order to share it with a rival weeks before he resigned. 

  • March 28, 2025

    MSD Loses Appeal Over Ruling It Broke 'Merck' Branding Ban

    A London appeals court upheld on Friday a ruling that U.S.-based Merck Sharp & Dohme LLC breached a court order blocking its use of the name "Merck" in a move to safeguard German rival Merck KGaA's trademark rights.

  • March 28, 2025

    AstraZeneca Can't Stop Generic Diabetes Drug Launch

    AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    AstraZeneca Fights Generic Diabetes Drug Launch

    AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    Warner Bros 'Multiversus' UK TM Gets Green Light

    Warner Bros. can register a trademark for its online multiplayer game Multiversus, after British officials ruled that gamers would think it was entirely disconnected from a rival firm's "Versus" brand.

  • March 27, 2025

    Parties Can Dodge Costs By Surrendering Patents, UPC Says

    Parties facing challenges to their patents can swerve liability for their opponent's costs by giving up their intellectual property protections at the outset of the dispute, an appeals panel at the Unified Patent Court has ruled.

  • March 27, 2025

    Beverage Biz Can't Corner The Market For 'Norwich City' TM

    U.K. trademark officials have chucked a drinks maker's bid for a "Norwich City" trademark for alcoholic drinks, rejecting the company's argument that it should be allowed because the city's football club already owns a trademark for "Norwich City FC."

  • March 27, 2025

    Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine

    An adviser to the European Union's top court said Thursday that it should uphold €60.5 million ($70.7 million) in fines against Teva and its subsidiary Cephalon for an alleged conspiracy to keep a generic version of Provigil off the shelves.

  • March 27, 2025

    Unitary Patent Uptake 'Surpassing Expectations,' EPO Says

    The European Patent Office has said it received more than 28,000 requests for unitary protection in its second year as more than a quarter of applicants sought to protect their inventions under the new framework.

  • March 26, 2025

    Claims Firm Beats Whistleblower's Fraud Case

    A claims manager didn't blow the whistle on forged signatures at an insurance claims handler because he had waited until his resignation day to alert senior management, an employment tribunal has ruled.

  • March 26, 2025

    Software Developer Loses 'Baidu' TM On Appeal

    A Dutch provider of software for TV channels has lost its rights to use "Baidu" as a trademark, after a European court found that it hadn't used the name to market goods and services it had applied for.

  • March 26, 2025

    Bacardi Halts Counterfeit Grey Goose Bottles At Dutch Court

    Bacardi has convinced a Dutch court to bar a Hong Kong drinks trader from selling counterfeit Grey Goose vodka in the Netherlands, after the court found the company had infringed Bacardi's protected branding.

  • March 26, 2025

    Cannabis Event Biz Loses Bid For 'Cannafair' TM

    A European court threw out a challenge by cannabis trade fair company Cannafair on Wednesday over the decision by European trademark officials to refuse a trademark for the name of its event, ruling that its name was a literal description of the event.

  • March 26, 2025

    Lotus Biscoff Loses EU Appeal To Register Color TM

    Lotus Bakeries NV has lost another bid to protect the red and white coloring of its biscuit packaging after failing to convince European officials that shoppers would immediately recognize its brand.

  • March 26, 2025

    EU Court Upholds Polish Biz's Rights To Public Toilet Design

    A European Union court has rejected a Polish company's latest bid to quash a rival's protections for a public toilet design, ruling Wednesday that the design was new and consequently valid.

  • March 25, 2025

    Portuguese Bag Maker Can't Nix Rival 'Cavallini' TM

    European officials have ruled that an Italian designer can sell leather goods and clothing using the trademark "about a boy Erika Cavallini" because shoppers would understand it wasn't related to Cavalinho-branded bags and accessories. 

  • March 25, 2025

    Amazon Can't Make Last-Minute Tweaks In Nokia UPC Clash

    Amazon has lost its bid to file additional grounds of appeal in a patent dispute with Nokia over video-coding technology after Europe's patent court held that it wouldn't be fair to its Finnish rival.

  • March 25, 2025

    Roche Voids Biogen's Protein Production Patent At EPO

    The European Patent Office has stripped Biogen of its protein production patent amid Roche's protests, ruling in a decision released Tuesday that the tech lacks novelty in light of a key ruling from the agency's top appeals panel.

  • March 25, 2025

    Ex-Private Equity Exec Denies Data Theft, Alleges Misconduct

    A former manager at private equity firm Appian Capital Advisory LLP has denied stealing the company's data and poaching staff and clients, telling a London court the business sued him after pushing him out because he voiced concerns about his boss's misconduct.

  • March 25, 2025

    Football Shirt Biz Can't Show Red Card To Rival's TM Bid

    A retro football shirt retailer has lost its attempt to boot out a competitor's "Scoreline" U.K. trademark application, failing to prove that shoppers could confuse the mark with its own "Score Draw" branding.

  • March 24, 2025

    Zara Owner Narrows Tanzanian Safari Co.'s Trademark

    Zara's parent company has persuaded U.K. trademark officials to trim the scope of a Tanzanian tour company's "Zara Tours" trademarks but failed to convince them that its right to use the mark should be scrapped entirely.

  • March 24, 2025

    Chinese Co. Avoids Sales Ban In Videoconference Patent Feud

    A Belgian technology company has lost its bid to block a Chinese rival from selling videoconference devices ahead of a full patent infringement trial because the request was filed too late.

  • March 24, 2025

    PepsiCo's Cheetos Brand Can't Block Rival's 'Cheezo' TM

    PepsiCo has failed to convince British officials to stop a rival from registering "Cheezo" as a trademark, ruling that shoppers wouldn't think the Cheetos-maker had expanded into the chocolate wafer market.

Expert Analysis

  • Teva Case Aims Europe's Pharma Crackdown At IP Loophole

    Author Photo

    The European Commission's recent allegations against Teva signal not only the EU competition watchdog's continued focus on intellectual property violations in the pharmaceutical sector but also its new enforcement interest in exclusionary disparagement, say Robert Bell and Malgorzata Janiec at Armstrong Teasdale.

  • Determining Whether To Opt Out Of New Unified Patent Court

    Author Photo

    The new United Patent Court, made up of judges from all European Union member states, will cover the new unitary patent and European patents unless the owner chooses to opt out during the transition period, so patent proprietors must consider whether to opt out for each patent family, say Steffen Steininger and Anna-Katharina Friese-Okoro at Hogan Lovells.

  • 10 Things To Know About The Coming EU Unified Patent Court

    Author Photo

    When the Unified Patent Court opens next year, it will represent a paradigm shift for adversarial patent proceedings in Europe, and practitioners should familiarize themselves now with this new, centralized litigation system, say Fabian Koenigbauer at Ice Miller and Thomas Kronberger at Grünecker.

  • 7 Key Takeaways For Litigating Willful Patent Infringement

    Author Photo

    Brian Nolan and Manuel Velez at Mayer Brown explore the impact of the Federal Circuit's 2021 SRI International v. Cisco Systems decision, and six other areas recent parties have focused on when litigating willful infringement in the latest case law.

  • Trademark Ruling Brings Clarity To Product Defect Liability

    Author Photo

    The recent Court of Justice of the EU ruling in Fennia v. Philips, its first concerning the trademark aspect of producer liability in Article 3(1) of Directive 85/374, brings greater clarity to the question of compensation in the event of a claim for defective products, say Radboud Ribbert and Thomas van Weeren at Greenberg Traurig.

  • Appointments Shape EU Unified Patent Court Before Launch

    Author Photo

    A series of judiciary appointments at the EU Unified Patent Court help put the court on track for its April opening, while also reflecting a patent-friendly enforcement system, say attorneys at Baker McKenzie.

  • 5 Considerations In Preparing For EU's New Patent System

    Author Photo

    With the upcoming implementation of the unitary patent and Unified Patent Court, Europe gets closer to its long-term goal of one EU patent that can be enforced in one court, and non-EU patent owners and applicants will have strategic decisions to make, say Fabian Koenigbauer at Ice Miller and Thomas Kronberger at Grünecker.

  • Reexamining Negative Limitations After Novartis Patent Ruling

    Author Photo

    The Federal Circuit's decision and denial of rehearing in Novartis v. Accord has created exacting standards that must be met in order for negative limitations in patent claims to satisfy the written description requirement, but whether the dissent is correct that the majority opinion heightened the standard is an arguable point, say Jonathan Fitzgerald and Jaime Choi at Snell & Wilmer.

  • UK Courts' 3rd-Party Disclosure Rule Sets Global Precedent

    Author Photo

    The quiet change about to take place in the English Civil Procedure Rules, enabling U.K. courts to require pre-action disclosure of information from overseas third parties, is uncharted territory and will have profound implications for any organization that handles assets on behalf of a party, says Simon Bushell at Seladore Legal.

  • Zara TM Ruling Shows Prefiling Clearance Is Always Advisable

    Author Photo

    The recent Trade Mark Tribunal decision regarding Zara and House of Zana demonstrates the importance of conducting prefiling clearance investigations, so that where opposition may be anticipated, a strategy can be put in place, says Melanie Harvey at Birketts.

  • Dutch Merger May Promote Behavioral Remedies Across EU

    Author Photo

    A Dutch tribunal's recent clearing of the Sanoma-Iddink deal might further encourage merging parties in the EU to offer — and government agencies to accept — behavioral remedies, which was rarer when more emphasis was put on divestments, says Robert Hardy at Greenberg Traurig.

  • How Will UK Address AI Patent Infringement?

    Author Photo

    As artificial intelligence-related patent litigation activity inevitably approaches, a review of U.K. principles of direct and indirect liability offers insight into how courts may address questions involving cloud-based technology and arguments related to training AI models, say Alexander Korenberg at Kilburn & Strode and Toby Bond at Bird & Bird.

  • Law Commission's 'Data Objects' Proposal Is Far-Reaching

    Author Photo

    The Law Commission’s proposals to recognize data objects as a new category of personal property would bring fundamental changes were they to be implemented, and would have significant ramifications for finance litigation, say attorneys at Norton Rose.

  • UK Rulings Give Chinese Courts Wide Powers In IP Disputes

    Author Photo

    The recent rulings in Nokia v. Oppo and Philips v. Oppo open the door for Chinese courts to adjudicate worldwide rate-setting terms for standard-essential patents, and in so doing present a timely wake-up call as to China's influence, say F. Scott Kieff at George Washington University Law School and Thomas Grant at the University of Cambridge.

  • Swatch V. Samsung Offers IP Warning To Platform Operators

    Author Photo

    The recent U.K. High Court decision of Swatch v. Samsung demonstrates that while platform operators may wish to exercise greater control over the apps distributed on their platforms, this carries with it a corresponding duty to apply due diligence to protect the intellectual property rights of third parties, say Alex Borthwick and William Hillson at Powell Gilbert.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!